CUG-279

N/A

Report date: 2023/11/01 09:29:03

Base Information

Drug NameCUG-279
Drug Alias NameVitoKine 2CUG-279
ClassificationBiologics
Mechanisms of ActionInterleukin-2 replacementsT lymphocytes stimulants
TargetsInterleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCugene Inc
China Registration ClassN/A

Develop Information

Active CompaniesCugene Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A